Gujarat Alkalies and Chemicals (GUJALKALI)₹601.75−0.90%Commodity Chemicals
In the Jun 2026 quarter (consolidated), Gujarat Alkalies and Chemicals reported sales of ₹1,248 Cr, up 12.8% from Jun 2025, and net profit of ₹54.84 Cr. For the year to Mar 2026, sales were ₹4,368 Cr and net profit −₹1.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 972 | 923 | 1,004 | 979 | 993 | 1,031 | 1,078 | 1,107 | 1,085 | 1,046 | 1,128 | 1,248 |
| Expenses | 956 | 942 | 999 | 923 | 946 | 952 | 975 | 1,011 | 1,010 | 948 | 1,016 | 1,024 |
| Operating Profit | 16.03 | −20.03 | 4.01 | 54.14 | 46.09 | 78.14 | 101 | 95.17 | 74.21 | 96.18 | 110 | 223 |
| OPM % | 1.7% | −2.2% | 0.4% | 6.1% | 4.7% | 8.1% | 9.1% | 9.1% | 7.1% | 9.1% | 10.1% | 18.1% |
| Other Income | 70.92 | 4.99 | 2.99 | 2.99 | 48.94 | 14.98 | 23.99 | 7.99 | 58.96 | 29.99 | 24.97 | 8.99 |
| Interest | 10.99 | 11.01 | 12.01 | 11.01 | 10.99 | 10.01 | 17.99 | 14.01 | 15.99 | 17.99 | 14.99 | 15.99 |
| Depreciation | 94.64 | 95.71 | 96.74 | 96.63 | 99.70 | 97.61 | 96.72 | 102 | 104 | 104 | 104 | 103 |
| Profit before tax | −17.97 | −123 | −102 | −49.92 | −15.98 | −14.96 | 9.99 | −11.98 | 13.96 | 3.99 | 14.97 | 112 |
| Tax % | 0.0% | −6.0% | −54.9% | −10.9% | 15.0% | −26.9% | 13.0% | 15.1% | −20.9% | 621.1% | 3.0% | 51.1% |
| Net Profit | −17.95 | −115 | −45.90 | −44.90 | −17.93 | −10.96 | 8.97 | −13.95 | 15.96 | −19.95 | 14.94 | 54.84 |
| EPS (Rs) | −2.49 | −15.66 | −6.28 | −6.05 | −2.47 | −1.52 | 1.19 | −1.87 | 2.22 | −2.71 | 2.03 | 7.48 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,999 | 2,074 | 2,459 | 3,166 | 2,732 | 2,435 | 3,767 | 4,527 | 3,816 | 4,084 | 4,368 | 4,506 |
| Expenses | 1,660 | 1,622 | 1,671 | 2,047 | 2,149 | 2,074 | 2,777 | 3,570 | 3,779 | 3,797 | 3,978 | 3,998 |
| Operating Profit | 336 | 449 | 787 | 1,117 | 578 | 358 | 986 | 950 | 32.09 | 280 | 383 | 503 |
| OPM % | 17.1% | 22.1% | 32.1% | 35.1% | 21.1% | 15.1% | 26.1% | 21.1% | 0.8% | 7.1% | 9.1% | 11.2% |
| Other Income | 44.97 | 55.95 | 106 | 61.91 | 89.93 | 66.96 | 45.95 | 41.99 | 89.94 | 91.97 | 117 | 123 |
| Interest | 10.01 | 13.01 | 15.01 | 21.01 | 14.01 | 14.99 | 6.01 | 19.01 | 45.03 | 50.99 | 62.99 | 64.96 |
| Depreciation | 107 | 111 | 127 | 140 | 161 | 174 | 197 | 275 | 376 | 391 | 413 | 414 |
| Profit before tax | 261 | 380 | 747 | 1,014 | 490 | 234 | 824 | 694 | −299 | −70.90 | 20.95 | 145 |
| Tax % | 16.0% | 19.0% | 29.1% | 32.1% | 32.1% | 29.1% | 32.1% | 41.1% | −20.9% | −9.0% | 112.1% | — |
| Exceptional items | −1.01 | 1.01 | 34.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | — |
| Net Profit | 219 | 306 | 532 | 688 | 331 | 166 | 558 | 409 | −236 | −64.76 | −1.99 | 65.79 |
| EPS (Rs) | 29.88 | 41.77 | 72.68 | 93.93 | 45.14 | 22.53 | 76.08 | 55.69 | −32.23 | −8.86 | −0.32 | 9.02 |
| Dividend payout % | 14.9% | 11.9% | 9.0% | 9.0% | 18.0% | 34.9% | 12.9% | 41.9% | −43.1% | −178.1% | −5,394.1% | — |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 73.11 | 73.10 | 73.10 | 73.13 | 73.08 | 73.07 | 73.07 | 73.09 | 73.12 | 73.07 | 73.09 |
| Reserves | 2,856 | 3,283 | 3,750 | 4,224 | 4,523 | 5,301 | 5,825 | 6,069 | 6,003 | 5,596 | 5,118 |
| Borrowings | 296 | 354 | 292 | 248 | 206 | 500 | 596 | 599 | 546 | 563 | 577 |
| Other Liabilities | 674 | 729 | 863 | 993 | 1,095 | 1,288 | 1,491 | 1,607 | 1,411 | 1,764 | 1,774 |
| Total Liabilities | 3,900 | 4,441 | 4,977 | 5,539 | 5,898 | 7,162 | 7,985 | 8,347 | 8,033 | 7,998 | 7,545 |
| Fixed Assets | 1,825 | 2,078 | 2,110 | 2,305 | 2,617 | 2,593 | 2,709 | 4,260 | 4,624 | 4,592 | 4,352 |
| CWIP | 82.89 | 151 | 252 | 307 | 444 | 1,106 | 1,783 | 543 | 94.83 | 78.86 | 122 |
| Investments | 856 | 1,018 | 1,148 | 1,068 | 1,245 | 2,097 | 2,115 | 1,836 | 2,098 | 1,981 | 1,637 |
| Other Assets | 1,136 | 1,195 | 1,468 | 1,858 | 1,592 | 1,365 | 1,378 | 1,708 | 1,217 | 1,346 | 1,433 |
| Inventories | 184 | 169 | 264 | 230 | 235 | 225 | 352 | 459 | 406 | 484 | 449 |
| Trade receivables | 325 | 328 | 402 | 486 | 373 | 288 | 302 | 284 | 178 | 263 | 406 |
| Cash & equivalents | 49.87 | 131 | 134 | 270 | 43.88 | 356 | 299 | 482 | 161 | 134 | 171 |
| Total Assets | 3,900 | 4,441 | 4,977 | 5,539 | 5,898 | 7,162 | 7,985 | 8,347 | 8,033 | 7,998 | 7,545 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 200 | 501 | 513 | 836 | 628 | 420 | 734 | 958 | 66.85 | 380 | 405 |
| Cash from investing activity | −352 | −467 | −395 | −580 | −634 | −334 | −804 | −662 | −90.03 | −264 | −228 |
| Cash from financing activity | 83.80 | 12.97 | −116 | −136 | −146 | 225 | 11.95 | −140 | −276 | −145 | −150 |
| Net cash flow | −67.18 | 49.12 | 3.01 | 122 | −150 | 314 | −58.14 | 158 | −302 | −28.09 | 28.10 |
| Capex | 268 | 376 | 180 | 323 | 413 | 158 | 908 | 682 | 231 | 324 | 258 |
| Free cash flow | −79.80 | 62.86 | 229 | 450 | 55.90 | −369 | −173 | 276 | −163 | 58.81 | 148 |
| CFO / OP % | 74.9% | 132.0% | 82.9% | 97.9% | 120.9% | 132.9% | 105.9% | 120.9% | 352.9% | 111.9% | 99.9% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 | 24 | 34 |
| Inventory days | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 | 110 | 102 |
| Days payable | 100 | 126 | 155 | 135 | 127 | 112 | 102 | 120 | 87 | 116 | 112 |
| Cash conversion cycle | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 | 19 | 25 |
| Working capital days | 89 | 81 | 98 | 96 | 107 | 10 | 4 | 5 | −1 | −3 | 1 |
| ROCE % | — | 10.9% | 18.0% | 23.9% | 10.9% | 5.0% | 12.9% | 11.0% | −4.0% | 0.0% | 1.0% |
For the Jun 2026 quarter, Gujarat Alkalies and Chemicals reported sales of ₹1,248 Cr, up 12.8% year on year and net profit of ₹54.84 Cr. The operating margin was 18.1%.
Gujarat Alkalies and Chemicals' sales for the year to Mar 2026 were ₹4,368 Cr; over the last twelve months they were ₹4,506 Cr.
Net profit for the year to Mar 2026 was −₹1.99 Cr, and ₹65.79 Cr over the last twelve months. Earnings per share over the same trailing period were ₹9.02.
Gujarat Alkalies and Chemicals reported borrowings of ₹577 Cr at Mar 2026, against cash and equivalents of ₹171 Cr.
Cash from operations was ₹405 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹148 Cr.